GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
V

Vicapsys Life Sciences VICP · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.50

—

Close of 4 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

About Vicapsys Life Sciences

From its filings with the US Securities and Exchange Commission

SEC filings

Vicapsys Life Sciences is based in Cumming, Georgia and is incorporated in Florida. Its shares trade on OTC under the ticker VICP. The SEC classifies its business as pharmaceutical preparations. In the fiscal year to 31 December 2023, it reported a net loss of $1.2m. At that date it held total assets of $39,656 and shareholders' equity of −$1.9m.

Read the filing on SEC.gov ↗

Company facts

Sector
Health Care
Industry
Biotechnology
Listed since
11 Jul 2001
Head office
1735 BUFORD HIGHWAY, CUMMING, GA, 30041
Incorporated in
FL
Classification
Pharmaceutical Preparations
Filer status
Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

Leadership

Pay as last reported

  • Mr. Federico PierChief Executive Officer, Executive Chairman of the Board, since 2019$120,000
  • Mr. Jeffery WrightChief Financial Officer$90,000
  • Dr. Dorothy JordanDirector
  • Dr. Colleen DelaneyIndependent Director
  • Mr. Charles FarraharIndependent Director
  • Mr. Richard RosenblumIndependent Director

Environmental, social and governance

Scores out of 100, from our data supplier

ESG
Overall
0
Environment
0
Social
0
Governance
0

SWOT analysis

AI-generated by our data supplier. Not written or checked by our editors.

AI-generated

Strengths

  • Headquartered in Cumming, Georgia, United States
  • Operates in the Health Care sector within Biotechnology
  • IPO date of 2001-07-11 provides historical market presence

Weaknesses

  • No specific financial data provided for analysis
  • No product or service details mentioned in the source
  • No market share or competitive position information available

Opportunities

  • Biotechnology sector growth potential in Health Care
  • IPO in 2001 may allow for long-term strategic planning
  • Geographic location in Cumming, Georgia, may offer regional advantages

Threats

  • No specific threats identified in the provided information
  • Biotechnology sector faces regulatory challenges
  • Lack of detailed financial data may hinder risk assessment

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.